This short article describes the usage of tumor necrosis factor (TNF) inhibitors in children, reviews the pharmacology of the agents, and reviews and summarizes the existing safety information designed for etanercept, adalimumab, and infliximab. in scientific studies and limited case reviews. However, predicated on the data obtainable, TNF inhibitors have already 164656-23-9 been implicated in… Continue reading This short article describes the usage of tumor necrosis factor (TNF)